GR3019708T3 - Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals - Google Patents

Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals

Info

Publication number
GR3019708T3
GR3019708T3 GR960401091T GR960401091T GR3019708T3 GR 3019708 T3 GR3019708 T3 GR 3019708T3 GR 960401091 T GR960401091 T GR 960401091T GR 960401091 T GR960401091 T GR 960401091T GR 3019708 T3 GR3019708 T3 GR 3019708T3
Authority
GR
Greece
Prior art keywords
wounds
enhance
healing
repair
enhancing
Prior art date
Application number
GR960401091T
Other languages
English (en)
Inventor
Martin Schwarz
Lee M Sullivan
Loretta A Bober
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of GR3019708T3 publication Critical patent/GR3019708T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
GR960401091T 1991-01-10 1996-04-22 Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals GR3019708T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63963191A 1991-01-10 1991-01-10
PCT/US1992/000024 WO1992011861A1 (en) 1991-01-10 1992-01-07 Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals

Publications (1)

Publication Number Publication Date
GR3019708T3 true GR3019708T3 (en) 1996-07-31

Family

ID=24564917

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401091T GR3019708T3 (en) 1991-01-10 1996-04-22 Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals

Country Status (11)

Country Link
EP (2) EP0566661B1 (el)
JP (1) JPH0747545B2 (el)
AT (1) ATE135233T1 (el)
AU (1) AU660959B2 (el)
CA (1) CA2099263C (el)
DE (1) DE69209051T2 (el)
DK (1) DK0566661T3 (el)
ES (1) ES2085003T3 (el)
GR (1) GR3019708T3 (el)
IE (1) IE75707B1 (el)
WO (1) WO1992011861A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206345A (en) * 1990-08-02 1993-04-27 Fred Hutchinson Cancer Research Center Il-4 and tnf induce mab 6g10-recognized expression on bone marrow stromal cells
WO1994021282A1 (en) * 1993-03-19 1994-09-29 Immunex Corporation Pharmaceutical compositions comprising a ligand complexed with a soluble receptor
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
GB2430031A (en) * 2005-09-07 2007-03-14 Ethicon Inc Diagnostic markers of wound infection
EP4422668A1 (en) * 2021-10-25 2024-09-04 Ellennbe GmbH Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
EP0302429B1 (en) * 1987-08-03 1993-07-28 Tasuku Honjo Novel human interleukin 4, expression vectors for human interleukin 4 and transformants containing the same
JPH0611706B2 (ja) * 1989-01-20 1994-02-16 ザ ユニバーシティ オブ メルボルン フィブリン溶解
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
HUT63062A (en) * 1990-03-21 1993-07-28 Schering Corp Process for producing pharmaceutical compositions increasing the immune response and comprising il-4

Also Published As

Publication number Publication date
AU660959B2 (en) 1995-07-13
AU1198092A (en) 1992-08-17
CA2099263C (en) 1997-03-11
EP0566661B1 (en) 1996-03-13
EP0502599A1 (en) 1992-09-09
EP0502599B1 (en) 1996-03-13
DE69209051D1 (de) 1996-04-18
ES2085003T3 (es) 1996-05-16
EP0566661A1 (en) 1993-10-27
JPH0747545B2 (ja) 1995-05-24
ATE135233T1 (de) 1996-03-15
JPH05509333A (ja) 1993-12-22
IE75707B1 (en) 1997-09-10
DE69209051T2 (de) 1996-08-08
IE920070A1 (en) 1992-07-15
WO1992011861A1 (en) 1992-07-23
DK0566661T3 (da) 1996-07-01
CA2099263A1 (en) 1992-07-11

Similar Documents

Publication Publication Date Title
FI924778A7 (fi) GM-CSF:n ja G-CSF:n käyttö haavojen paranemisen nopeuttamiseksi
DE68917300D1 (de) Heilung von wunden.
DE3785758D1 (de) Wundheilung und knochenregeneration.
EP1736152A3 (en) Physiologically stable compositions of butyric acid as well as butyric acid salts and derivatives for treating wounds
AU7565091A (en) Use of copper(ii) containing compounds to accelerate wound healing
AU1811788A (en) Promotion of healing of meniscal tissue
GB8811409D0 (en) Cosmetic composition
NO894643L (no) Sammensatt kompresjons- og stoettebandasje.
SE8703625D0 (sv) New medical use
DE3874813D1 (de) Zusammensetzung zur behandlung der haut.
DE69327263D1 (de) Verwendung des Gewebefaktor-Inhibitors zur Herstellung eines Arzneimittels gegen Mikrogefässthrombose
DE69031218D1 (de) Wundheilung
DE58906031D1 (de) Topisch anwendbare pharmazeutische Zubereitung.
AU506683B2 (en) Dental treatment chair
AU1286192A (en) Promotion of wound-healing with 15-keto prostaglandin compounds
DE69209051D1 (de) Verwendung von il-4 zur verstärkung von wundheilung und besserung und zur heilung von infizierten wunden und wunden bei diabetischen säugetieren
ATE151977T1 (de) Therapeutisch wirksame, örtliche anwendung von st1435
HU9500098D0 (en) Lysosyme dimer and compositions containing the same
GB9101191D0 (en) Wound treatment
DK0951294T3 (da) Sårhelende formuleringer indeholdende humanplasmafibronectin
ATA4993A (de) Topische zusammensetzung zur beschleunigung der wundheilung
RU96104062A (ru) Средство "витадерм" в комплексной терапии ожоговых ран
ATE113828T1 (de) Kosmetische zusammensetzung.
GB2260702B (en) Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X
AU3764689A (en) Use of local anaesthetic agents in the manufacture of preparations with wound healing effect